Lv2
158 积分 2025-04-08 加入
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
4天前
已完结
Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis
5天前
已完结
Indirect comparison of statin–ezetimibe and statin–PCSK9 inhibitor combination therapies for coronary artery plaque regression in acute coronary syndrome
7天前
已完结
Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: A phase 3 study
8天前
已完结
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
22天前
已完结
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
26天前
已完结
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
26天前
已完结
Plozasiran and Apolipoprotein C-III Inhibition
1个月前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
2个月前
已完结
Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial
2个月前
已完结
皖公网安备34019202002308
